Nicolet Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

Nicolet Advisory Services's BMY Position: Q4 2025 in Review

Nicolet Advisory Services increased its Bristol-Myers Squibb (BMY) stake by 19% in Q4 2025, buying an estimated $140K and bringing the position to 18,088 shares worth $1.01M. The position accounts for 0.07% of the portfolio, ranked #139.

Nicolet Advisory Services first reported a position in BMY in Q1 2020 and has held it in 20 quarters since. 2,448 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

• Nicolet Advisory Services held 18,088 shares of Bristol-Myers Squibb worth $1.01M as of Q4 2025.
• Nicolet Advisory Services bought 2,906 Bristol-Myers Squibb shares in Q4 2025, an estimated $140K.
• Bristol-Myers Squibb made up 0.07% of Nicolet Advisory Services's portfolio in Q4 2025, its #139 holding.
• Nicolet Advisory Services first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 20 quarters since.
• 2,448 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Nicolet Advisory Services's 13F filing for Q4 2025, filed 13 Feb 2026.